JAKE SIMSON

Profile

First Name

: JAKE

Middle Name

:

Last Name

: SIMSON

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

AAVANTIBIO, INC.

BARRY J. BYRNE, M.D., PH.D., MANUELA CORTI, PT, PH.D., BO CUMBO, ELLEN HUKKELHOVEN, PH.D., PHILIP R. JOHNSON, M.D., BENJAMIN LUND, DOUGLAS J. SWIRSKY

DIRECTOR

DICE MOLECULES HOLDINGS, LLC

JOHN BEDBROOK, SHAAN GANDHI, PEHR HARBURY, KEVIN JUDICE, PHILLIP PATTEN, MICHAEL RABSON, SCOTT ROBERTSON, MICHAEL RUBIN, RICHARD SCHELLER, JIM SCOPA, SHARON TETLOW, STEPHEN ZACHARY

DIRECTOR

CEDILLA THERAPEUTICS, INC.

CHRIS BOWDEN, ELI CASDIN, ABBIE CELNIKER, NEIL EXTER, ALEXANDRA GLUCKSMANN, ROSANA KAPELLER, DOMINIK NACZYNSKI

DIRECTOR

CONVERGENT THERAPEUTICS, INC.

NEIL BANDER, ALEXANDER BROWN, PHILIP KANTOFF, ERIC SULLIVAN, JIM TRENKLE, TAL ZAKS

DIRECTOR

ABRAHAM BASSAN, ELIZABETH BHATT, ALAN EZEKOWITZ, JEFFREY FINER, SAMIRA SHAIKHLY, JEFFREY TONG, RAN XIAO

DIRECTOR

OUTPACE BIO, INC.

VASUDEV BAILEY, SCOTT BOYKEN, AARON FOSTER, BAHIJA JALLAL, MARC LAJOIE, CHARITY SCRIPTURE, ERIC SOLLER

DIRECTOR

VIVACE THERAPEUTICS, INC.

SHENG DING, EDWARD HU, LEONARD POST, SHUANG QIAO, TIM SHANNON, JUN WU, CHENGUANG ZHOU

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2025-02-28

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-07-31

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-07-17

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-06-28

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-04-27

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-09-09

D

OTHER TECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2021-08-20

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-12-18

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-10-21